AusBiotech will be leading missions to the world's largest and most relevant biotech and medtech events over the coming months - in Shanghai, Hong Kong, Korea and USA - to support Australian companies in their outreach and global development.

Sienna Cancer Diagnostics has selected former Immune System Therapeutics CEO Dr Cliff Holloway to serve as interim chief executive while a permanent replacement is found.

As the problem of antimicrobial resistance grows worldwide, over 30 European academic partners and five pharmaceutical companies have launched a new project under the New Drugs 4 Bad Bugs (ND4BB) program. [ + ]

Patrys's (ASX:PAB) PAT-SM6 anticancer candidate met its primary safety and tolerability endpoints during a phase I/IIa multiple myeloma trial.

Clinical Genomics has appointed a new VP for APAC and VP of regulatory affairs as part of a global expansion strategy for its colorectal cancer screening products.

Dr David Mitchell has been appointed chief executive officer of the Australian Centre for Plant Functional Genomics Ltd in Adelaide.

AusBiotech is inviting session proposals for life science conference AusBiotech 2015. This is your opportunity to have a say and lead discussions, bringing new and diverse topics to the forefront of the life sciences industry.

Australian researchers have identified a new method that could help tell the difference between highly aggressive and more benign forms of triple-negative breast cancer (TNBC). [ + ]

AXT has won a competitive tender to supply a high-end X-ray diffractometer (XRD) to The University of Queensland (UQ). The system that won the tender is a 9 kW Rigaku SmartLab featuring a rotating anode X-ray generator. [ + ]

On 27 February, the University of Sydney will host the first Zoobiquity conference ever to be held outside North America. Zoologists, molecular biologists and human and veterinary physicians will come together as they adopt an interdisciplinary approach to nutrition and disease in humans and animals. [ + ]

A simple farm-based method for producing biofuels and feed for animals. [ + ]

Australian researchers have identified a new method that could help tell the difference between highly aggressive and more benign forms of triple-negative breast cancer (TNBC). [ + ]

AusBiotech calls on leaders of biotechnology companies (CEOs and MDs) to respond to the annual Biotechnology Industry Position Survey 2015, enabling them to contribute to the annual snapshot and build the advocacy platform for the year to come.

Researchers from the Fram Centre in Norway are conducting studies in Arctic waters to determine whether the combined effect of several pollutants could be more severe than the sum of their individual effects. [ + ]

Orthocell (ASX:OCC) has been awarded a US patent covering the use of its Celgro collagen bio-scaffold in soft tissue reconstruction applications. [ + ]